Skip to main content

next-generation sequencing

Research Reports
09/19/2023
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and...
09/19/2023
Journal of Clinical Pathways
Review
09/19/2023
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon...
09/19/2023
Journal of Clinical Pathways
Conference Coverage
02/03/2021
Journal of Clinical Pathways
News
06/16/2020
A study presented at the European Hematology Association (EHA) Virtual Meeting (June 11-21, 2020) sought to identify biomarkers in patients with relapsed or refractory non-germinal center B-cell-like (non-GCB)...
A study presented at the European Hematology Association (EHA) Virtual Meeting (June 11-21, 2020) sought to identify biomarkers in patients with relapsed or refractory non-germinal center B-cell-like (non-GCB)...
A...
06/16/2020
Journal of Clinical Pathways
Chronic foot wounds, whether diabetic or nondiabetic, yield a multilayered, polymicrobial community of fast and slow growing aerobic and anaerobic bacteria, as well as fungus, yeast, and ...
11/27/2019